Fesoterodine
Fesoterodine is listed in the FDA National Drug Code directory with 2 NDC codes. Available dosage form: powder.
Drug Details
- Generic Name
- Fesoterodine
- Brand Names
- N/A
- Application Number
- Sponsor
- Raks Pharma Pvt. Limited
- NDC Codes
- 2
- Dosage Forms
- POWDER
- Routes
- N/A
- Active Ingredients
- FESOTERODINE FUMARATE, FESOTERODINE
Indications and Usage
1 INDICATIONS AND USAGE Fesoterodine fumarate extended-release are indicated for the treatment of: • Overactive bladder(OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency. ( 1.1 ) • Neurogenic detrusor overactivity (NDO) in pediatric patients 6 years of age and older and weighing greater than 25 kg. ( 1.2) 1.1 Adult Overactive Bladder Fesoterodine fumarate extended-release tablets are indicated for the treatment of overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency. 1.2 Pediatric Neurogenic Detrusor Overactivity Fesoterodine fumarate extended-release tablets are indicated for the treatment of neurogenic detrusor overactivity (NDO) in pediatric patients 6 years of age and older with a body weight greater than 25 kg.